Patenting EPO analogs: screening vs. predictability.
Kelly
P
P
Haverstock, Garrett & Roberts, St. Louis, MO 63101.
D004353:Drug Evaluation, Preclinical; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D015202:Protein Engineering; D014481:United States
D004921:Erythropoietin